NCT06215846 2025-11-26A Clinical Study Evaluating the Safety and Efficacy of BioTTT001 in Patients With Malignant Solid TumorsBeijing Bio-Targeting Therapeutics Technology Co., LtdPhase 1 Enrolling by invitation12 enrolled